Back to ROYAL BANK OF CANADA ROYAL BANK OF CANADA

VRNAVRNA
14 quarters

Position history for ROYAL BANK OF CANADAROYAL BANK OF CANADA's holdings in <![CDATA[VERONA PHARMA ADR PLC ADR]]>

As of its Q3 2025 13F, Royal Bank of Canada held 2,075 shares of VRNA (<![cdata[verona Pharma ADR PLC Adr]]>), worth $221,000. Royal Bank of Canada's 13F filings listed VRNA from Q3 2022 to Q3 2025, 13 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$7,000

Total Shares Change

-726

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%—
0
2025-Q3
Decreased
2,075
-67.8%
$221,0000.0%—
0
2025-Q2
Decreased
6,453
-33.6%
$609,0000.0%—
0
2025-Q1
Increased
9,719
+43.3%
$617,0000.0%—
33
2024-Q4
Increased
6,781
+351.8%
$315,0000.0%—
38
2024-Q3
Decreased
1,501
-2.1%
$43,0000.0%—
0
2024-Q2
Decreased
1,533
-1.7%
$21,0000.0%—
0
2024-Q1
Increased
1,559
+3.9%
$25,0000.0%—
14
2023-Q4
Decreased
1,501
-0.1%
$30,0000.0%—
0
2023-Q3
Decreased
1,503
-4.6%
$24,0000.0%—
0
2023-Q2
Decreased
1,575
-9.6%
$34,0000.0%—
0
2023-Q1
Increased
1,742
+0.6%
$35,0000.0%—
14
2022-Q4
Increased
1,732
+138.6%
$45,0000.0%—
22
2022-Q3
New
726
-
$7,0000.0%—
25

Other major holders of VRNA: Janus Henderson Group Ltd., Pentwater Capital Management LP, HBK INVESTMENTS L P, BlackRock, Inc., FIL Ltd

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used